Emerging Role of GLP-1 Receptor Agonists in Bipolar Disorder Treatment

TL;DR
This review explores the potential of glucagon-like peptide-1 (GLP-1) receptor agonists as emerging treatments for bipolar disorder, summarizing preclinical and clinical evidence supporting their therapeutic role in mood regulation, neuroprotection, and metabolic health.
Topics:technologymedical-research#bipolar-disorder#clinical-evidence#glp-1-receptor-agonists#medical-research#preclinical-studies#therapeutics
Want the full story? Read the original reporting
Read on Nature